We like to predict the future of telemedicine. But these predictions are often speculative. The most likely trends in telemedicine ...
In recent weeks, the CDC has struggled with policy reversals and communication errors. Yet its leaders continue to project confidence ...
The Supreme Court ruled against vaccine mandates for large employers. It was an expected ruling that fell along partisan lines. ...
Media outlets have become the primary source of healthcare information, replacing traditional clinical journals. But the difference between the two ...
It is only a matter of time before we hear of the fourth COVID booster. The timing will correspond with ...
The FDA has authorized multiple COVID treatments, but they remain limited for the foreseeable future due to the belief that ...
Climate change is a healthcare issue. But it affects healthcare at large more than it does individual patients. Therefore, we ...
Public health is a field that thrives on compromise. Yet we have polarized and distorted it into something different. By ...
The push to decentralize healthcare will be defined by a shift in power from hospitals to payer networks. The shift ...
Healthcare venture capital has enjoyed unprecedented growth. A trend that will continue as healthcare embraces new reimbursement models - because ...
Clinical research is the heart of clinical medicine. It defines what we know. More importantly, it defines how we think. ...
We consider progress in healthcare as a march towards efficiency. But efficiency is limited by patient behavior, which can be ...
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy